By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.
Peter Attia MD181 - Viewing cancer through an evolutionary lens: a radically different approach to treatment
Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.
At a glance
WHAT IT’S REALLY ABOUT
Evolutionary Ecology Reframes Cancer Treatment: Adaptive Therapy and Extinction Strategies
- Gatenby describes moving from physics to medicine and radiology, then building mathematical population models of cancer after finding oncology research lacked organizing first principles.
- Drawing on pest-management ecology, he argues that hitting tumors with maximum doses selects for resistance, while adaptive therapy preserves drug-sensitive cells that outcompete costly resistant ones.
- His pilot prostate cancer trial with abiraterone showed median time to progression of 30 months versus 14 months for standard care, with four patients still cycling after five years.
- He proposes an 'extinction' strategy that follows an initial response with a sequence of further perturbations and then immunotherapy as a 'closer', exploiting how small, fragmented tumor populations are vulnerable.
- He acknowledges strong resistance from the oncology community, funding and incentive obstacles for off-patent drugs, and limits on how well tumor heterogeneity and metastasis are understood.
IDEAS WORTH REMEMBERING
5 ideasMaximum-dose treatment can select for resistance.
Using the pesticide analogy, Gatenby says killing the sensitive cells clears space for the resistant ones, which gives short-term gains but long-term loss of control.
Resistance carries a fitness cost that can be exploited.
When drug is withdrawn, sensitive cells outcompete resistant cells, so cycling therapy can hold resistant populations in check.
The pilot trial results exceeded the model's predictions.
Median time to progression was 30 months versus 14 months, and the models, which had guessed a fitness ratio of two or three, found sensitive cells were roughly sevenfold fitter. Patients with three well-timed cycles saw resistant cells driven toward extinction.
Small, fragmented tumor populations are especially vulnerable.
Stochastic effects and Allee effects mean tumors reduced to small islands struggle to build blood supply, matrix, and immune evasion, so Gatenby argues for striking again rather than waiting for progression.
Cancer may need a series of good bullets, not a magic bullet.
Gatenby notes that most extinctions in nature are multi-cause and multi-event, and he compares this to pediatric leukemia treatment, where induction is followed immediately by other drugs.
WORDS WORTH SAVING
5 quotesIn cancer, we're always looking for the magic bullet, the one that will eradicate the cancer and not, and, and not the normal cells. And for de- for a century, we, we've been looking for magic bullets, but maybe all we need is a series of pretty good bullets.
— Robert Gatenby
It's not a boxing match. It's a knife fight. You know, we, this is to the death. And, and that means that when you knock your opponent down, you don't stand back and wait. You go attack.
— Robert Gatenby
You've got a lot of literature, but I don't know that you have a lot of knowledge.
— Robert Gatenby
If it's that complicated, then you have to have mathematics. I mean, you, you, there's, there's no way that the, that the human brain is gonna understand complex systems without sufficient, you know, mathematics.
— Robert Gatenby
The greatest risk is to our egos and to the dogma as opposed to the patients.
— Peter Attia
High quality AI-generated summary created from speaker-labeled transcript.
